Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

U.S. vaccine advisers unanimously favor Pfizer/BioNTech shot after approval

Stock MarketsAug 30, 2021 05:41PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: Vials of the Pfizer-BioNTech vaccine are pictured in a vaccination centre in Geneva, Switzerland, February 3, 2021. REUTERS/Denis Balibouse

By Manas Mishra and Julie Steenhuysen

(Reuters) -An advisory panel to the U.S. Centers for Disease Control and Prevention (CDC) on Monday unanimously recommended the Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) COVID-19 vaccine for people age 16 and older, an important step that could help accelerate vaccine mandates in the United States.

The Food and Drug Administration last week granted full approval to the vaccine that was previously available under the agency's emergency use authorization (EUA), which had allowed the shots to be rolled out rapidly to Americans.

Health officials hope the formal approval and CDC recommendation will spur more Americans to get vaccinated. With full FDA approval, some companies and states have begun mandating COVID-19 vaccination.

Vaccination rates remain low in many parts of the United States, contributing to a big surge in hospitalizations due to the highly contagious Delta variant of the coronavirus.

Some panel members said increasing vaccinations before the fall season was critical to getting children back to schools safely.

"Everyone who has anything to do with a child that is not old enough to be vaccinated yet should be vaccinated for the benefit of their children," said Dr. Helen Keipp Talbot, an infectious disease specialist who was part of the panel.

Regulators have authorized a third dose of the Pfizer/BioNTech and Moderna (NASDAQ:MRNA) vaccines for those with weak immune systems, and the U.S. government has said it plans to make booster doses available to more Americans in September.

The CDC advisers are considering an approach to boosters that would focus on preventing severe disease among those most at risk - residents in long-term care facilities, other older adults and healthcare workers - much like the original vaccine rollout.

CDC staff presented available data on the need for boosters and said, at this point it may be difficult to determine whether immunity from prior vaccination is waning over time or if the vaccines are just less able to prevent infection by the highly-transmissible Delta variant.

Several panel members expressed concern about the White House announcement of a booster policy starting in September, even before the vaccine advisory panel had seen the evidence or determined that such a campaign was needed.

Members of the vaccine advisory working group, which is shaping the agency's approach to boosters, stressed that the top U.S. priority remains getting shots to the unvaccinated.

Another meeting will be scheduled in mid-September to discuss boosters.

At Monday's meeting, the CDC reiterated that the benefits of the Pfizer vaccine outweigh potential risks associated with the shots.

New Zealand on Monday reported its first death linked to Pfizer's COVID-19 vaccine after a woman suffered myocarditis, a type of inflammation of the heart muscle that is a known rare side effect of the vaccine. Health officials there said other factors could have contributed to her death.

There have been no reported deaths among young U.S. adults who developed myocarditis after getting the Pfizer/BioNTech vaccine, CDC said.

U.S. vaccine advisers unanimously favor Pfizer/BioNTech shot after approval
 

Related Articles

S&P 500 Rides Apple Rally Higher as Tech Fights Back
S&P 500 Rides Apple Rally Higher as Tech Fights Back By Investing.com - Jan 28, 2022 3

By Yasin Ebrahim Investing.com – The S&P 500 rallied Friday, as blowout quarterly results from Apple put tech back into the driving seat following a recent rout amid jitters about...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (9)
Whaling Trawler
Whaling Trawler Aug 31, 2021 1:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Cases of covid and delta are a good thing. It means our immune systems are working as God intended so I'll just pass in the devil's mark of the beast thanks...
JonMichael Patrick
JonMichael Patrick Aug 30, 2021 9:37PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
me and my wife both felt similar chest pain in the exact same spot after second shot. we are 35 and 36 and healthy weight etc
Eudon Hickey
Eudon Hickey Aug 30, 2021 9:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Rubbish article from the deep state. These “Vaccines” dont & only EUA was granted. Reuters should read the documents again
Vlad Lozovskiy
Vlad Lozovskiy Aug 30, 2021 7:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Now if vaccine would start working.
JonMichael Patrick
JonMichael Patrick Aug 30, 2021 7:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think it's doing exactly what it was designed todo
Vlad Lozovskiy
Vlad Lozovskiy Aug 30, 2021 7:11PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Tom Woosley
Tom Woosley Aug 30, 2021 6:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Vaccines that are < 50% effective and require 1 or x number of boosters afterwards...that doesn't give me much of a confidence level. I am sure that big pharma and likely most of Congress are getting rich.
Francesco Lucchesi
Francesco Lucchesi Aug 30, 2021 5:44PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
total scam, now we know it
Raymond Huggard
Raymond Huggard Aug 30, 2021 4:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Stop trying to force vaccines on people. Let them make their own choices. Them let nature take its course. We need a culling anyway.
Me comment
Me comment Aug 30, 2021 4:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It is a good thing polio and small pox didn't happen now versus years ago. With all the antivaccine and antiscience theororist the world population would probably less than a third of what it is now.
John Avenetti
John Avenetti Aug 30, 2021 3:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
worldwide scam. medical dictatorship
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email